@FiercePharma: Roche cedes power, jobs to Genentech. Article | Follow @FiercePharma
> Britain's health cost watchdog rejected Roche's (ROG.VX) cancer drug Herceptin for patients with stomach cancer "due to the uncertainty surrounding the extent to which it can extend life." Report
> Shares of Allergan, Biogen Idec and Genzyme popped on Friday, fueled by market speculation that Sanofi-Aventis might be considering a takeover of one of the companies. Report
> Sanofi-Aventis is set to sign an increased €7 billion ($8.6 billion) refinancing loan after attracting strong appetite from banks, bankers said. Article
> Investors led by Blackstone are taking a "substantial" stake in China Animal Healthcare, a Singapore-listed maker drugs for livestock that is hoping to boost its animal vaccine business. Story
> Par Pharmaceutical (PRX.N) said U.S. health regulators have approved its drug to prevent nausea and vomiting in patients who are treated for cancer. Report
> Roche Holding (ROG.VX) cancer drug Avastin, in combination with chemotherapy, helps women with ovarian cancer live longer without their disease worsening, a second late-stage study has shown. Story
> The United Arab Emirates pharmaceutical market will reach a value of $1.59 billion this year, growing 14.9 percent from last year's total of $1.38 billion, say new forecasts. Article
> United Therapeutics and Lee's Pharmaceutical announced that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) injection in China. Article
Biotech News
@FierceBiotech: Only the biggest developers can play the biosimilar game. Article | Follow @FierceBiotech
@JohnCFierce: If I was master of the universe, I'd have Pfizer buy Genzyme, Sanofi buy Biogen and Merck buy Allergan. All announced on the same day. | Follow @JohnCFierce
> Adverse cardio effects derail testosterone gel study. News
> Nycomed wins EU approval for COPD therapy. Report
> Sanofi's rumored buyout plans inspire guessing game. Story
> Stem cell player moves to Mass. Article
Biotech Research News
> Roche, IBM team up on sequencing breakthrough. News
> New study points to compound's role in brain diseases. Story
> Researchers: Chemical injection can restore hearing. Report
> Compugen protein "abolishes" relapses in MS animal study. Article
Biotech IT News
> CRO Accovion tailors Oracle safety database. Story
> Cleveland Clinic finds high Avandia cardio risk. Item
> Survey: Companies leery of social media, cloud/SaaS data security. Article
Manufacturing News
> Pharma Associates taps Axway for EDI management. News
> Catalent ups supply chain visibility with social media model. Item
> Packaging contributes to approval for Sagent's heparin. Story
> Incineration of flu vax shows pandemic supply/demand challenge. Article
And Finally... Men taking drugs for sexual potency showed almost triple the rate of sexually transmitted diseases compared with those not taking the medications, a Harvard University study found. Report